Mendelian Randomization Study on Causal Association of Pyroglutamine with COVID-19.
Wenting SuShan ZhouGaizhi ZhuYaqi XuRan GaoMin ZhangQi ZengRenxi WangPublished in: Journal of epidemiology and global health (2022)
Our analysis suggests a causal link between genetically increased pyroglutamine and reduced risk of COVID-19. Thus, pyroglutamine may be a protective factor for patients with COVID-19.